Literature DB >> 20139253

Case report. Fractionated Helical Tomotherapy as an alternative to radiosurgery in patients unwilling to undergo additional radiosurgery for recurrent brain metastases.

P Sanghera1, A W Lightstone, D E Hyde, P Davey.   

Abstract

Our clinic routinely treats brain metastases with stereotactic radiosurgery using a 6 megavoltage (MV) linear accelerator, cones, and a surgically attached head frame. Four patients declined repeat radiosurgery for new lesions due to their previous discomfort and a fifth patient could not complete radiosurgery because of uncontrolled nausea. Instead patients were treated with Helical Tomotherapy (HT). This report discusses the spatial dose distribution of HT as measured in a head phantom and the clinical course of these five patients. The planning target volume (PTV) was a 3 mm geometric expansion of the gross tumour volume (GTV). The prescribed dose to the PTV was 27 Gy in five daily fractions with the distribution optimised to deliver 30 Gy to the GTV. Patients were immobilised with a mask and the lesions were targeted by MV computerised tomography, an inherent feature of the system. One patient died six weeks later from systemic disease; the remaining patients survived eight to 16 months. No patient experienced an exacerbation of neurological symptoms following Helical Tomotherapy. These results suggest that fractionated Helical Tomotherapy for brain metastases may be a viable alternative to radiosurgery in patients unable or unwilling to undergo that procedure.

Entities:  

Mesh:

Year:  2010        PMID: 20139253      PMCID: PMC3473529          DOI: 10.1259/bjr/19238690

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  15 in total

1.  Radiotherapy of the brain in elderly patients. Contra:.

Authors:  A A Brandes; A Rigon; S Monfardini
Journal:  Eur J Cancer       Date:  2000-03       Impact factor: 9.162

Review 2.  Image guidance for precise conformal radiotherapy.

Authors:  Thomas Rockwell Mackie; Jeff Kapatoes; Ken Ruchala; Weiguo Lu; Chuan Wu; Gustavo Olivera; Lisa Forrest; Wolfgang Tome; Jim Welsh; Robert Jeraj; Paul Harari; Paul Reckwerdt; Bhudatt Paliwal; Mark Ritter; Harry Keller; Jack Fowler; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038

Review 3.  The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.

Authors:  Minesh P Mehta; May N Tsao; Timothy J Whelan; David E Morris; James A Hayman; John C Flickinger; Michael Mills; C Leland Rogers; Luis Souhami
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-01       Impact factor: 7.038

4.  Dosimetric comparisons of helical tomotherapy treatment plans and step-and-shoot intensity-modulated radiosurgery treatment plans in intracranial stereotactic radiosurgery.

Authors:  Chunhui Han; An Liu; Timothy E Schultheiss; Richard D Pezner; Yi-Jen Chen; Jeffrey Y C Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-01       Impact factor: 7.038

5.  Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.

Authors:  E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-05-01       Impact factor: 7.038

6.  Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

Authors:  P K Sneed; K R Lamborn; J M Forstner; M W McDermott; S Chang; E Park; P H Gutin; T L Phillips; W M Wara; D A Larson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-02-01       Impact factor: 7.038

7.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

Authors:  L Gaspar; C Scott; M Rotman; S Asbell; T Phillips; T Wasserman; W G McKenna; R Byhardt
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-01       Impact factor: 7.038

8.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

Authors:  R A Patchell; P A Tibbs; W F Regine; R J Dempsey; M Mohiuddin; R J Kryscio; W R Markesbery; K A Foon; B Young
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

9.  Adaptation and verification of the relocatable Gill-Thomas-Cosman frame in stereotactic radiotherapy.

Authors:  H M Kooy; S F Dunbar; N J Tarbell; E Mannarino; N Ferarro; S Shusterman; M Bellerive; L Finn; C V McDonough; J S Loeffler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-10-15       Impact factor: 7.038

10.  Computer-assisted positioning of radiotherapy patients using implanted radiopaque fiducials.

Authors:  K P Gall; L J Verhey; M Wagner
Journal:  Med Phys       Date:  1993 Jul-Aug       Impact factor: 4.071

View more
  2 in total

1.  Evaluating novel radiation techniques for the treatment of cerebral metastases.

Authors:  A J Chalmers
Journal:  Br J Radiol       Date:  2010-02       Impact factor: 3.039

2.  Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting.

Authors:  Andrew Elson; Ashley Walker; Joseph A Bovi; Christopher Schultz
Journal:  Front Oncol       Date:  2015-02-09       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.